All
Jean-Francois Korobelnik, MD, says surgeons under-utilize a key surgical tool
At the 2025 EURETINA Congress, Prof Korobelnik delivered the Gisbert Richard Lecture, focusing on removal of intra-ocular foreign bodies and mitigating ocular trauma.
EURETINA 2025: María Berrocal, MD, shares wisdom from her Kreissig Award Lecture
María Berrocal, MD, titled her Kreissig Award Lecture "Throwing away wisdom: How we abandon what works."
EURETINA 2025: Elon van Dijk on central serous chorioretinopathy
Don't miss the Women in Retina networking breakfast at EURETINA
Prof Tunde Peto and Prof Catherine Creuzot-Garcher will serve on an educational panel during the networking event.
Neurotech Pharmaceuticals appoints Peter J. McDonnell, MD, to board of directors
Neurotech Pharmaceuticals enhances its leadership by appointing Peter J. McDonnell, MD, a leading ophthalmology expert, to its Board of Directors.
EURETINA 2025: Timothy Lai discusses the SALWEEN 1-year data
Progression rates vary in subtypes of geographic atrophy lesions
An understanding of GA growth kinetics is key to addressing the pathophysiology of age-related macular degeneration.
Contivue port delivery platform for nAMD receives CE mark
Roche's Contivue platform gains EU CE mark, offering innovative treatment for neovascular AMD with fewer injections and promising long-term vision outcomes.
EURETINA 2025: Aleksandra Rachitskaya and Danilo Iannetta on the Vit-Buckle Symposium
Aleksandra Rachitskaya, MD, FASRS, is a member of the Modern Retina editorial advisory board.
Ashvattha announces positive topline data for MGB for the treatment of DME and nAMD
EURETINA 2025: Marion Munk, Md, PhD, discusses the IntRIS symposium
The International Retinal Imaging Society (IntRIS) had a significant presence at this year's EURETINA Congress.
Ursula Schmidt-Erfurth, MD, discusses her keynote EURETINA Lecture
In her keynote address, Prof Schmidt-Erfurth focused on new artificial intelligence tools and their usage in addressing age-related macular degeneration.
EURETINA leadership welcome record-breaking number of attendees
This year's EURETINA meeting boasts a crowd of 10,000 attendees, including delegates, industry leaders, and young retina specialists.
Ramin Tadayoni Award 2025 winner announced at EURETINA Congress
Prithvi Ramtohul, MD, is a PhD candidate based in Marseille, France and previously completed a fellowship in Paris under Prof. Tadayoni.
PulseSight to highlight new data on the role of iron and transferrin in AMD at EURETINA 2025
Study finds value in home OCT monitoring
AI enhances home OCT imaging to track wet AMD disease activity, enabling personalized patient management and improved treatment response monitoring.
BVI unveils new Virtuoso surgical platform
BVI launches Virtuoso, a groundbreaking dual-function surgical platform for cataract and vitreoretinal procedures, enhancing efficiency and control in surgery.
Outlook Therapeutics requests Type A meeting with FDA following second CRL for ONS-5010
Outlook Therapeutics seeks FDA clarity on ONS-5010 after a complete response letter, aiming to address efficacy concerns for wet AMD treatment.
The Eye Care Network's clinical advisors will present at EURETINA
Where to find members of our editorial board at this year's European Society of Retina Specialists Congress.
EURETINA Innovation Spotlight kickstarts the 2025 Congress
Anat Loewenstein, MD, president of EURETINA, announces the EURETINA Innovation Spotlight (EIS) will return on September 3 this year.
AAVantgarde, Ocular Therapeutix, Oculis announce EURETINA presentations
Leading companies to unveil new research on retinal diseases at EURETINA 2025, showcasing innovative therapies and clinical trial results.
EMA grants Orphan designations to MCO-010, FDA grants RMAT in Stargardt disease
MCO-010 receives Orphan and RMAT designations, highlighting its potential as a groundbreaking therapy for various retinal dystrophies.
identifeye HEALTH launches retinal screening platform
Starting from scratch on neovascular age-related macular degeneration
AMD treatment may become unrecogniable as gene therapies evolve.
Q&A: Vicky Demas on the value of easy to use imaging tools and the potential of AI
identifeye HEALTH unveils a retinal screening platform, enhancing accessibility and efficiency in patient care through innovative technology and AI integration.
Prevent Blindness implements Diabetes + the Eyes Advisory Committee to combat diabetes-related eye diseases
The committee will work to help the organization increase awareness and early identification of diabetes-related eye diseases and improve access to eye care treatment, policy development, research, and surveillance.
Retina roundup: August 25 to August 29
Catch up on this week's highlights in retina.
FDA issues complete response letter to Outlook Therapeutics for resubmitted BLA for ONS-5010
FDA issues a complete response letter to Outlook Therapeutics for ONS-5010, citing insufficient evidence of effectiveness for wet AMD treatment.
XLRP, RP, and wet AMD trial data slotted for presentation at EURETINA 2025
Researchers examine brain immune cell impact on the eye
Researchers used adaptive optics scanning light ophthalmoscopy (AOSLO) to study retinas in mice with photoreceptor damage, specifically photoreceptor laser injury.
